Exclusion of Fluoroscopy Use in Catheter Ablation Procedures: Six Years of Experience at a Single Center

• Published in: Journal of cardiovascular electrophysiology Vol. 25; no. 6; pp. 638 - 644
• Main Authors: FERNÁNDEZ-GÓMEZ, JUAN M., MORIÑA-VÁZQUEZ, PABLO, MORALES, ELENA DEL RIO, VENEGAS-GAMERO, JOSÉ, BARBA-PICHARDO, RAFAEL, CARRANZA, MANUEL HERRERA
• Format: Journal Article
• Language: English
• Published: United States Blackwell Publishing Ltd 01.06.2014; Wiley Subscription Services, Inc
• Subjects: Adult; Aged; atrial flutter; AV node reentry; catheter ablation; Catheter Ablation - methods; Catheter Ablation - trends; Female; Fluoroscopy - methods; Fluoroscopy - trends; fluoroscopy WPW syndrome; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Tachycardia, Supraventricular - diagnosis; Tachycardia, Supraventricular - epidemiology; Tachycardia, Supraventricular - therapy; Time Factors; Treatment Outcome; fluoroscopy WPW syndrome; catheter ablation; AV node reentry; atrial flutter
• ISSN: 1045-3873; 1540-8167
• DOI: 10.1111/jce.12385

Exclusion of Fluoroscopy Use in Catheter Ablation Procedures Background Nonfluoroscopic mapping systems have demonstrated significant reduction of radiation exposure in radiofrequency (RF) catheter ablation procedures. However, their use as only imaging guide is still limited. Objective To evaluate the usefulness of a completely nonfluoroscopic approach to catheter ablation of supraventricular arrhythmias using the Ensite‐NavX™ electroanatomical navigation system. Methods During 6 years, all consecutive patients referred for RF catheter ablation of regular supraventricular tachycardia (SVT) were admitted for a “zero‐fluoroscopy” approach and studied prospectively. The only exclusion criterion was the need to perform a transseptal puncture. Results A total of 340 procedures were performed on 328 patients (179 men, age 55.7 ± 18.6 years). One hundred fifty‐three patients had typical atrial flutter (AFL), 146 had AV nodal reentrant tachycardia (AVNRT), 35 had AV reciprocating tachycardia (AVRT), 4 patients had incisional atrial flutter (IAF), and 2 had focal atrial tachycardia (AT). Procedural success was achieved in 337 of the cases (99.1%). In 322 (94.7%), the procedure was completed without any fluoroscopy use. Mean procedure time was 110.5 ± 51.8 minutes. Mean RF application time was 9.8 ± 12.8 minutes and the number of RF lesions was 16.43 ± 15.8. Only 1 major complication related to vascular access was recorded. During follow‐up, there were 12 recurrences (3.5%) (8 patients from the AVNRT group, 4 patients from the AP group). Conclusion RF catheter ablation of SVT with an approach completely guided by the NavX system and without use of fluoroscopy is feasible, safe, and effective.